Cancer treatments are typically prescribed for tumors specific to a region of the body. However, last May, the FDA approved the first cancer treatment that can be used for tumors located anywhere in the body, as long as it carries a specific type of genetic mutation: Keytruda (pembrolizab). It is an immune checkpoint inhibitor that can treat any solid…

Read More

Traditionally, preoperative chemotherapy without radiation is used following the standard Britsh regimen which combines epirubicin platinum and 5-FU (both drugs used for chemotherapy). However, recently the Germans developed the FLOT regimen which essentially is a modified FOLFOX with an addition of docetaxel. Following this development, they decided to compare their new regimen FLOT versus the old regimen ECF…

Read More

John Hopkins Kimmel Cancer Center researchers developed a single blood test that can detect for eight common cancer types through assessment of the circulating proteins and mutations in cell-free DNA. The test, called CancerSEEK, is a unique noninvasive, multianalyte test that simultaneously evaluates levels of eight cancer proteins and the presence of cancer gene mutations…

Read More

Gastrointestinal toxicity is common during cancer therapy, and most treatment options are not helpful for the majority of patients. A recent study using a mixture of amino acids show decreases in mucositis and gastrointestinal toxicity following irradiation. This study was conducted in order to evaluate how the amino acid-based beverage benefited cancer patients receiving chemotherapy…

Read More

Medical marijuana can exist in a variety of formulations such as dried flowers, resins, extracts and oils. It’s legalization and use for medical purposes is still a developing issue and the perspectives of many health care providers is also following the same path. Medical marijuana can be used to ease chronic pain, chemotherapy-induced nausea and…

Read More

DDF’s Scientific and Medical Advisory Board Chair, David Ilson, MD, PhD, explains that when it comes to a patient with metastatic disease molecular testing does have an impact on choices of therapy. More specifically HER2 testing is a common in patients with metastatic disease. If a patient is HER2-positive, then trastuzumab is included as part…

Read More